Inventor
PACHTER JONATHAN A
US22 patents
⚠️ This page may combine multiple inventors who share the name “PACHTER JONATHAN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
16 patentsUS7217796B2May 15, 2007
Neutralizing human anti-IGFR antibody
SCHERING CORP105 citations98
US6710037B2Mar 23, 2004
Method of treating androgen-dependent disorders
SCHERING CORP23 citations91
US7851181B2Dec 14, 2010
Neutralizing human anti-IGFR antibody
SCHERING CORP7 citations73
US7847068B2Dec 7, 2010
Neutralizing human anti-IGFR antibody
SCHERING CORP7 citations73
US7811562B2Oct 12, 2010
Biomarkers for pre-selection of patients for anti-IGF1R therapy
SCHERING CORP7 citations73
US7667021B2Feb 23, 2010
Neutralizing human anti-IGFR antibody
SCHERING CORP6 citations73
US7138396B2Nov 21, 2006
17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP3 citations62
US6903102B2Jun 7, 2005
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP3 citations62
US7790474B1Sep 7, 2010
p53 modulators
SCHERING CORP2 citations59
US5461057AOct 24, 1995
Hydro-ethano-indeno-pyridines
SCHERING CORP1 citations52
US7485645B2Feb 3, 2009
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP1 citations51
US7432268B2Oct 7, 2008
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP1 citations51
US7271175B2Sep 18, 2007
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP1 citations51
US7053091B2May 30, 2006
17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP0 citations51
US8017735B2Sep 13, 2011
Anti-IGFR1 antibody therapeutic combinations
SCHERING CORP1 citations49
US6569872B1May 27, 2003
Use of neurokinin receptor antagonists to treat androgen-dependent diseases
SCHERING CORP1 citations39
VERASTEM INC
4 patentsUS10532056B2Jan 14, 2020
Therapeutic compositions, combinations, and methods of use
VERASTEM INC6 citations80
US10406158B2Sep 10, 2019
Methods and compositions for treating abnormal cell growth
VERASTEM INC5 citations79
US9962385B2May 8, 2018
Methods and compositions for treating abnormal cell growth
VERASTEM INC6 citations79
US11564927B2Jan 31, 2023
Therapeutic compositions, combinations, and methods of use
VERASTEM INC1 citations59